Jen Monnier is an intern at Spectrum. She is a journalist in New York City, covering medicine, technology and ecosystems. She’s also a graduate student at New York University’s Science, Health and Environmental Reporting program.
Jen Monnier
From this contributor
Early interventions, explained
The accepted wisdom in autism research holds that early intervention offers the best promise for an autistic child’s well-being. But how effective are these therapies?
Multipart device monitors various senses in babies
A new assemblage of tools precisely gauges a baby’s biological response to sights, sounds and tactile stimuli all at once.
Multipart device monitors various senses in babies
New consortium may create projects, funding for autism research
A newly formed group of leaders from the U.S. National Institutes of Health (NIH) is poised to generate funding opportunities for child health research, including autism science.
New consortium may create projects, funding for autism research
Glowing capsule illuminates problems in gut
An ingestible electronic capsule enables researchers to instantaneously detect molecules associated with gastrointestinal issues.
Explore more from The Transmitter
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.